TD Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.09B Buy
1,190,111
+5,929
+0.5% +$6.01M 0.89% 27
2025
Q4
$1.27B Buy
1,184,182
+277,600
+31% +$265M 1.02% 23
2025
Q3
$692M Sell
906,582
-306,848
-25% -$228M 0.56% 35
2025
Q2
$946M Sell
1,213,430
-89,716
-7% -$69.7M 0.81% 28
2025
Q1
$1.08B Buy
1,303,146
+45,409
+4% +$37.8M 0.99% 20
2024
Q4
$971M Sell
1,257,737
-105,653
-8% -$87.5M 0.86% 24
2024
Q3
$1.2B Sell
1,363,390
-76,362
-5% -$68.7M 1.06% 18
2024
Q2
$1.3B Sell
1,439,752
-39,845
-3% -$31.9M 1.22% 15
2024
Q1
$1.15B Sell
1,479,597
-475,486
-24% -$338M 1.07% 16
2023
Q4
$1.14B Buy
1,955,083
+23,758
+1% +$13.9M 1.12% 15
2023
Q3
$1.04B Buy
1,931,325
+81,692
+4% +$42.1M 1.26% 16
2023
Q2
$867M Buy
1,849,633
+75,366
+4% +$31.6M 0.99% 19
2023
Q1
$609M Buy
1,774,267
+463,879
+35% +$156M 0.74% 23
2022
Q4
$479M Sell
1,310,388
-50,424
-4% -$17.9M 0.59% 34
2022
Q3
$449M Sell
1,360,812
-36,699
-3% -$11.6M 0.56% 38
2022
Q2
$453M Sell
1,397,511
-30,024
-2% -$9.01M 0.53% 41
2022
Q1
$409M Sell
1,427,535
-145,162
-9% -$37.4M 0.37% 53
2021
Q4
$434M Buy
1,572,697
+463,989
+42% +$118M 0.36% 61
2021
Q3
$256M Sell
1,108,708
-40,565
-4% -$10M 0.27% 81
2021
Q2
$280M Buy
1,149,273
+320,741
+39% +$64.4M 0.28% 79
2021
Q1
$155M Buy
828,532
+102,826
+14% +$20.1M 0.17% 108
2020
Q4
$123M Sell
725,706
-100,004
-12% -$14.9M 0.15% 124
2020
Q3
$122M Buy
825,710
+75,472
+10% +$11.7M 0.17% 121
2020
Q2
$123M Sell
750,238
-98,501
-12% -$15.1M 0.18% 118
2020
Q1
$118M Buy
848,739
+121,751
+17% +$16.7M 0.2% 104
2019
Q4
$95.5M Buy
726,988
+44,887
+7% +$5.2M 0.14% 135
2019
Q3
$76.3M Sell
682,101
-41,424
-6% -$4.61M 0.12% 156
2019
Q2
$80.2M Sell
723,525
-285,814
-28% -$33.7M 0.12% 144
2019
Q1
$131M Sell
1,009,339
-15,826
-2% -$1.92M 0.2% 96
2018
Q4
$119M Sell
1,025,165
-9,933
-1% -$1.11M 0.21% 95
2018
Q3
$111M Sell
1,035,098
-25,122
-2% -$2.51M 0.16% 112
2018
Q2
$90.5M Sell
1,060,220
-48,640
-4% -$4M 0.14% 134
2018
Q1
$85.8M Buy
1,108,860
+3,563
+0.3% +$287K 0.13% 143
2017
Q4
$93.4M Sell
1,105,297
-15,924
-1% -$1.35M 0.14% 129
2017
Q3
$95.9M Sell
1,121,221
-56,039
-5% -$4.6M 0.14% 123
2017
Q2
$96.9M Sell
1,177,260
-86,002
-7% -$7.02M 0.15% 116
2017
Q1
$106M Buy
1,263,262
+47,787
+4% +$3.83M 0.17% 110
2016
Q4
$89.4M Sell
1,215,475
-410,397
-25% -$30.6M 0.15% 116
2016
Q3
$130M Sell
1,625,872
-348
-0% -$27.9K 0.23% 91
2016
Q2
$128M Buy
1,626,220
+194,064
+14% +$14.6M 0.23% 91
2016
Q1
$103M Sell
1,432,156
-233,676
-14% -$17.7M 0.19% 100
2015
Q4
$140M Buy
1,665,832
+101,446
+6% +$8.42M 0.28% 73
2015
Q3
$131M Buy
1,564,386
+27,951
+2% +$2.36M 0.26% 70
2015
Q2
$128M Sell
1,536,435
-17,699
-1% -$1.35M 0.23% 82
2015
Q1
$113M Sell
1,554,134
-140,123
-8% -$9.98M 0.2% 101
2014
Q4
$117M Buy
1,694,257
+478,833
+39% +$32.3M 0.19% 99
2014
Q3
$78.8M Buy
1,215,424
+238,613
+24% +$15.1M 0.14% 129
2014
Q2
$60.7M Sell
976,811
-15,233
-2% -$909K 0.1% 153
2014
Q1
$58.4M Sell
992,044
-16,270
-2% -$908K 0.11% 151
2013
Q4
$51.4M Buy
1,008,314
+33,446
+3% +$1.67M 0.1% 158
2013
Q3
$49.1M Sell
974,868
-31,150
-3% -$1.63M 0.1% 158
2013
Q2
$49.4M Buy
+1,006,018
New +$54.7M 0.11% 150

Other funds holding LLY

TD Asset Management's LLY Position: Q1 2026 in Review

TD Asset Management increased its Eli Lilly (LLY) stake by 0.5% in Q1 2026, buying an estimated $6.01M and bringing the position to 1,190,111 shares worth $1.09B. The position accounts for 0.89% of the portfolio, ranked #27.

TD Asset Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.3B in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • TD Asset Management held 1,190,111 shares of Eli Lilly worth $1.09B as of Q1 2026.
  • TD Asset Management bought 5,929 Eli Lilly shares in Q1 2026, an estimated $6.01M.
  • Eli Lilly made up 0.89% of TD Asset Management's portfolio in Q1 2026, its #27 holding.
  • TD Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • TD Asset Management's Eli Lilly position peaked at $1.3B in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.